Evidence map›Paper›PMID 35833271›Full record

ArticleNeurology2021

Futures Planning at the AAN: Approach and Initial Outcome.

Carlayne E Jackson, Lyell K Jones, Brad C Klein, Natalia R Rost, Sarah M Benish, Bruce T Levi, Robert A Gross, 2019–2021 AAN and AANI Boards of Directors and the AAN Executive Team

Abstract read
In one paragraph

Article in Neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Carlayne E JacksonFrom the University of Texas Heath Science Center (C.E.J.), San Antonio; Mayo Clinic (L.K.J.), Rochester, MN; private practice (B.C.K.), Abington, PA; Harvard Medical School (N.R.R.), Boston, MA; University of Minneapolis (S.M.B.); American Academy of Neurology (B.T.L.), Minneapolis, MN; and University of Rochester Medical Center (R.A.G.), NY. jacksonce@uthscsa.edu.
Lyell K JonesFrom the University of Texas Heath Science Center (C.E.J.), San Antonio; Mayo Clinic (L.K.J.), Rochester, MN; private practice (B.C.K.), Abington, PA; Harvard Medical School (N.R.R.), Boston, MA; University of Minneapolis (S.M.B.); American Academy of Neurology (B.T.L.), Minneapolis, MN; and University of Rochester Medical Center (R.A.G.), NY.
Brad C KleinFrom the University of Texas Heath Science Center (C.E.J.), San Antonio; Mayo Clinic (L.K.J.), Rochester, MN; private practice (B.C.K.), Abington, PA; Harvard Medical School (N.R.R.), Boston, MA; University of Minneapolis (S.M.B.); American Academy of Neurology (B.T.L.), Minneapolis, MN; and University of Rochester Medical Center (R.A.G.), NY.
Natalia R RostFrom the University of Texas Heath Science Center (C.E.J.), San Antonio; Mayo Clinic (L.K.J.), Rochester, MN; private practice (B.C.K.), Abington, PA; Harvard Medical School (N.R.R.), Boston, MA; University of Minneapolis (S.M.B.); American Academy of Neurology (B.T.L.), Minneapolis, MN; and University of Rochester Medical Center (R.A.G.), NY.
Sarah M BenishFrom the University of Texas Heath Science Center (C.E.J.), San Antonio; Mayo Clinic (L.K.J.), Rochester, MN; private practice (B.C.K.), Abington, PA; Harvard Medical School (N.R.R.), Boston, MA; University of Minneapolis (S.M.B.); American Academy of Neurology (B.T.L.), Minneapolis, MN; and University of Rochester Medical Center (R.A.G.), NY.
Bruce T LeviFrom the University of Texas Heath Science Center (C.E.J.), San Antonio; Mayo Clinic (L.K.J.), Rochester, MN; private practice (B.C.K.), Abington, PA; Harvard Medical School (N.R.R.), Boston, MA; University of Minneapolis (S.M.B.); American Academy of Neurology (B.T.L.), Minneapolis, MN; and University of Rochester Medical Center (R.A.G.), NY.
Robert A GrossFrom the University of Texas Heath Science Center (C.E.J.), San Antonio; Mayo Clinic (L.K.J.), Rochester, MN; private practice (B.C.K.), Abington, PA; Harvard Medical School (N.R.R.), Boston, MA; University of Minneapolis (S.M.B.); American Academy of Neurology (B.T.L.), Minneapolis, MN; and University of Rochester Medical Center (R.A.G.), NY.
2019–2021 AAN and AANI Boards of Directors and the AAN Executive Team

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe a process of organizational strategic future forecasting, with a horizon of 2035, as implemented by the American Academy of Neurology (AAN) on behalf of its members, and as a model approach for other organizations. The participants were members of the 2018-2020 AAN Boards of Directors and Executive Team, moderated by a consultant with expertise in future forecasting. Four predetermined model scenarios of import to our field (1 "expectable," 1 "challenging," and 2 "visionary") were discussed in small groups, with alternative scenarios developed in specific domains. Common themes emerged among all scenarios: the importance of thoughtful integration of biomedical and information technology tools into neurologic practice; continued demonstration of the value of neurologic care to society; and emphasis on population management and prevention of neurologic disease. Allowing for the inherent uncertainties of predicting the future, the AAN's integration of structured forecasting into its strategic planning process has allowed the organization to prepare more effectively for change, such as the disruptions stemming from the coronavirus disease 2019 (COVID-19) pandemic. The approaches outlined here will be integrated into future AAN operations and may be implemented to a similar effect by other organizations.

Indexed as

COVID-19NeurologyAcademies and InstitutesForecastingHumansSocieties, MedicalUnited States

Identifiers

PMID35833271
PMCPMC8205468

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.